Second primary tumors in squamous cell carcinoma of the head and neck-incidence, site, location, and prevention

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 8, Issue 2, 2000, Pages 87-90

  Sood, Sanjai ^a   Bradley, Patrick J ^b   Quraishi, M S ^b  

^a BRADFORD ROYAL INFIRMARY   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; RETINOIC ACID RECEPTOR; RETINOID;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CARCINOGENESIS; DRUG POTENTIATION; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SECOND CANCER; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

EID: 0034465010     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200004000-00003     Document Type: Review

References (39)

1. Multiple primary malignant tumors in patients with head and neck cancer: Results of a prospective study and future perspectives
2. Second primary malignancies in the head and neck cancer patient
3. Second primary tumors in patients with head and neck squamous cell carcinoma
4. Molecular epidemiology and retinoid chemoprevention of head and neck cancer
5. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer?
6. Synchronous and metachronous head and neck carcinomas
7. Second malignant neoplasia in patients with T1 glottic cancer treated with radiation
8. Second neoplasm in patients with head and neck cancer
9. The role of chemotherapy in the curative treatment of head and neck cancer
10. Role of chest CT scanning in the management of patients presenting with head and neck cancer
11. Multiple head and neck tumors: Evidence for a common clonal origin
12. Molecular support for field cancerization in the head and neck
13. Field cancerisation in the head and neck
14. The role of genetic factors in predisposition to squamous cell carcinoma of the head and neck
15. The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer
16. Genetic susceptibility to head and neck cancer: Interaction between nutrition and mutagen sensitivity
17. Reduced DNA repair capacity in head and neck cancer patients
18. Second laryngeal cancers in previously treated larynges
19. Metachronous cancer: Prognostic factors including prior irradiation
20. Photodynamic therapy and the treatment of head and neck neoplasia
21. Immunotherapy of head and neck cancer
22. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma
23. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients
24. Abrasive esophageal cytology for the oncological follow-up of patients with head and neck cancer
25. Head and neck cancer
26. The value of twice yearly bronchoscopy in the workup and follow-up of patients with laryngeal cancer
27. FDG PET in head and neck cancer
28. PET scanning in head and neck oncology: A review
29. Contact endoscopy during microlaryngeal surgery
30. Fluorescence spectroscopy: A technique with potential to improve the early detection of aerodigestive tract neoplasia
31. Smoking withdrawal and relapse in head and neck cancer patients
32. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer
33. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract
34. p53 Expressions: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma
35. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer
36. Increased expression of epidermal growth factor receptor in normal epithelium adjacent to head and neck carcinomas independent of tobacco and alcohol use
37. Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma lines
38. Retinoids and chemoprevention of aerodigestive tract cancers
39. Chemoprevention with interferon alpha and 13-cisretinoic acid in the adjunctive treatment of head and neck cancer